{"meta":{"query_hash":"5db7b903a306","filters":{"venue":"Journal of Immune Based Therapies and Vaccines"},"cohort_total":7,"direct_labels_cover":0,"predictions_cover":7,"exported":7,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5db7b903a306","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Immune+Based+Therapies+and+Vaccines"},"results":[{"id":"W1855748272","doi":"10.1186/1476-8518-4-1","title":"Cellular metabolism as a basis for immune privilege","year":2006,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Immune system; Immune privilege; Lipid metabolism; Hormone; Cell; Metabolism; Oxidative phosphorylation; Immunology; Cell biology; Medicine; Biology; Biochemistry","score_opus":0.009312431537668928,"score_gpt":0.2507508132480136,"score_spread":0.2414383817103447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1855748272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7233867,0.13759091,0.044024486,0.023869261,0.0014282789,0.000115280105,0.00020652576,0.0003438738,0.069034636],"genre_scores_gemma":[0.9816343,0.013093898,0.0022064168,0.00058383436,0.00022881539,0.000029368388,0.000038141825,0.0000064302612,0.0021788406],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9998745,0.000033849174,0.000006763368,0.000024730503,0.00002661508,0.000033567056],"domain_scores_gemma":[0.9999007,0.000018702356,0.000022450598,0.00001214429,0.000012613356,0.000033399843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025629875,0.00027159575,0.00032769766,0.00045299373,0.00032983717,0.00090895593,0.00030131877,0.00055966293,0.001434553],"category_scores_gemma":[0.00023294677,0.00010166269,0.0002426915,0.00011846672,0.0011740666,0.0008051977,0.0006335205,0.00073933013,0.00021835572],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097399735,0.00034559585,0.0165212,0.00069642183,0.00012121009,0.0051727793,0.00048268304,0.005610503,0.40352884,0.43242624,0.0033491186,0.13077138],"study_design_scores_gemma":[0.00014160783,0.0019334328,0.07708848,0.00049132365,0.00018614426,0.015532836,0.0010931487,0.016920563,0.2102184,0.54721886,0.12904681,0.00012840285],"about_ca_topic_score_codex":0.00018041894,"about_ca_topic_score_gemma":0.0001590368,"teacher_disagreement_score":0.001434553,"about_ca_system_score_codex":0.00049316057,"about_ca_system_score_gemma":0.00040221176,"threshold_uncertainty_score":0.004799068},"labels":[],"label_agreement":null},{"id":"W2012724561","doi":"10.1186/1476-8518-6-4","title":"CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection","year":2008,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Immunology; Hepatitis B vaccine; HBsAg; Vaccination; Adjuvant; Immune system; CpG Oligodeoxynucleotide; Cellular immunity; Lymphoproliferative response; Antigen; Hepatitis B; Population; Virology; Immunity; Hepatitis B virus; Virus; Biology","score_opus":0.018009466657890386,"score_gpt":0.2388374094307557,"score_spread":0.22082794277286533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012724561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976428,0.0016149677,0.00011568664,0.00008634569,0.00004854542,0.00013535435,0.000028054003,0.000016296493,0.00031177956],"genre_scores_gemma":[0.9975764,0.00085419585,0.000672879,0.00011445015,0.00008389666,0.00014874873,0.000051090854,0.000003979322,0.0004944006],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997633,0.00012936587,0.000021756958,0.000022468288,0.00002748612,0.000035464713],"domain_scores_gemma":[0.999435,0.00028020836,0.00011092527,0.000025764824,0.000033733708,0.000114339826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084494625,0.0002551297,0.0005741951,0.00019651777,0.00013545607,0.0002508785,0.00019309807,0.0005688377,0.0022737656],"category_scores_gemma":[0.0013000526,0.00023749711,0.00023196668,0.00013870171,0.00033631016,0.00029256757,0.00021724326,0.00070077425,0.00018016934],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36330014,0.03887993,0.02087775,0.0034775957,0.0008394468,0.000275046,0.0005031376,0.0013443386,0.30888012,0.00017702683,0.0010058631,0.26043966],"study_design_scores_gemma":[0.066563785,0.7955632,0.06597875,0.00028574778,0.0008191837,0.0003998685,0.00014718015,0.0014835595,0.0659094,0.00021216169,0.0026074627,0.000029648347],"about_ca_topic_score_codex":0.00016091533,"about_ca_topic_score_gemma":0.0003117625,"teacher_disagreement_score":0.0022737656,"about_ca_system_score_codex":0.00010334742,"about_ca_system_score_gemma":0.00023735788,"threshold_uncertainty_score":0.0076065063},"labels":[],"label_agreement":null},{"id":"W2104152758","doi":"10.1186/1476-8518-6-3","title":"Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers","year":2008,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Honeywell (Canada); Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; CpG Oligodeoxynucleotide; Virology; Immunology; Peripheral blood mononuclear cell; Chronic hepatitis; Virus; Computational biology; Biology; Genetics; Gene","score_opus":0.01831191028238305,"score_gpt":0.27172572196454653,"score_spread":0.2534138116821635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104152758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564064,0.001497242,0.0006566904,0.000061110746,0.000074290205,0.00008073167,0.00039265354,0.000011211397,0.0015854738],"genre_scores_gemma":[0.992082,0.0012877462,0.002557239,0.00021693789,0.00010706235,0.00025281153,0.001886473,0.00001315202,0.001596554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998197,0.000055745008,0.000021629872,0.000029407787,0.000036723122,0.000036877645],"domain_scores_gemma":[0.9997625,0.00012243095,0.000015150267,0.000015721262,0.000040294628,0.00004395517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026164245,0.0002942785,0.00022364549,0.00017995556,0.0001622451,0.00019257257,0.00008355912,0.0002423301,0.0021279298],"category_scores_gemma":[0.00034699877,0.00009590961,0.00015690752,0.00014515968,0.00012660417,0.00008944124,0.00016228949,0.00037636084,0.00046942933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017593023,0.00013400817,0.0013531597,0.00012469963,0.000010447236,0.000080067024,0.000077607256,0.00006000994,0.9905827,0.000014029283,0.00008926128,0.0057147765],"study_design_scores_gemma":[0.0004846418,0.012970312,0.053480465,0.000072919116,0.00015222815,0.0011153524,0.00021016142,0.0007900269,0.92612123,0.00006677881,0.0045155385,0.000020295693],"about_ca_topic_score_codex":0.00036234784,"about_ca_topic_score_gemma":0.00062800874,"teacher_disagreement_score":0.0021279298,"about_ca_system_score_codex":0.00009216722,"about_ca_system_score_gemma":0.00016558882,"threshold_uncertainty_score":0.0071185827},"labels":[],"label_agreement":null},{"id":"W2118464379","doi":"10.1186/1476-8518-4-7","title":"Longitudinal changes in HIV-specific IFN-γ secretion in subjects who received Remune™ vaccination prior to treatment interruption","year":2006,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"HIV Legal Network; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"Canadian Foundation for AIDS Research","keywords":"Medicine; Viremia; ELISPOT; Immunology; Viral load; Vaccination; Drug holiday; Immunity; Population; Virology; Immune system; Internal medicine; Human immunodeficiency virus (HIV); T cell","score_opus":0.023314137932389425,"score_gpt":0.2795082185347637,"score_spread":0.2561940806023743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118464379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994591,0.00011166561,0.00006181074,0.000010857443,0.0000044544836,0.000010019693,0.00008192928,0.000003763291,0.00025648763],"genre_scores_gemma":[0.9995431,0.000030844556,0.00004846365,0.00001539438,0.000005304865,0.000008559965,0.00015182498,8.400434e-7,0.00019568215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983215,0.000028131179,0.000013095819,0.000044563018,0.000029907496,0.0000521065],"domain_scores_gemma":[0.9992737,0.00012286236,0.00028256144,0.000047300124,0.000106228974,0.00016729704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004470132,0.00021140065,0.00023948676,0.00029555813,0.00033108666,0.00045558118,0.00013760476,0.00037422456,0.000956745],"category_scores_gemma":[0.0012614591,0.00013817527,0.0001759045,0.00025710178,0.00013388415,0.00024473024,0.00014147717,0.00062061864,0.00030740732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013693741,0.0001739895,0.99024373,0.0000098829005,0.00002395585,0.00014034953,0.00019882242,0.000042822114,0.0036580134,0.0000094396155,0.000067681154,0.0040620374],"study_design_scores_gemma":[0.000016324038,0.0016562386,0.9965444,0.000005593527,0.00003396973,0.00036122554,0.00012684152,0.00018414667,0.0007445685,0.000011481299,0.00031110973,0.0000040648897],"about_ca_topic_score_codex":0.0012883107,"about_ca_topic_score_gemma":0.0009047454,"teacher_disagreement_score":0.0012883107,"about_ca_system_score_codex":0.00018363394,"about_ca_system_score_gemma":0.00016610642,"threshold_uncertainty_score":0.0032006502},"labels":[],"label_agreement":null},{"id":"W2142025413","doi":"10.1186/1476-8518-8-4","title":"PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens","year":2010,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Saskatchewan","funders":"Krembil Foundation; Saskatchewan Health Research Foundation; Bill and Melinda Gates Foundation","keywords":"Adjuvant; Nasal administration; Immune system; Immunology; Medicine; Antigen; Immunization","score_opus":0.03500577706539187,"score_gpt":0.36762756564754484,"score_spread":0.33262178858215297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142025413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947319,0.0012753395,0.0022872952,0.000100188154,0.00004227702,0.00010885573,0.0002489842,0.00009813741,0.0011069452],"genre_scores_gemma":[0.9880432,0.001896848,0.00532637,0.000112798996,0.000042973366,0.0001648436,0.0004192152,0.000031676995,0.0039620213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998281,0.000029574932,0.0000138559535,0.000028671404,0.000048164344,0.00005166496],"domain_scores_gemma":[0.99981946,0.000036619105,0.00006220873,0.00001768806,0.000024494942,0.000039474948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029087183,0.00061949523,0.00030718555,0.00041513925,0.00009363931,0.00019224876,0.000199345,0.00041547514,0.0007801251],"category_scores_gemma":[0.0001651333,0.0001566537,0.00025768118,0.0001278941,0.00024999646,0.0003853767,0.00018386135,0.0010073386,0.00022462702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029472125,0.00019320533,0.00010737868,0.000049021233,0.0000047297963,0.000024109439,0.000011497829,0.00007839632,0.99728274,0.000022975919,0.000021452091,0.0019097837],"study_design_scores_gemma":[0.000037465372,0.004255929,0.0021261105,0.000009455635,0.000020705009,0.00008915272,0.000011545391,0.00035747304,0.9923064,0.000021611017,0.00076087797,0.000003222559],"about_ca_topic_score_codex":0.00025640678,"about_ca_topic_score_gemma":0.0004318902,"teacher_disagreement_score":0.0007801251,"about_ca_system_score_codex":0.00017993926,"about_ca_system_score_gemma":0.00019833921,"threshold_uncertainty_score":0.0026097894},"labels":[],"label_agreement":null},{"id":"W2165217477","doi":"10.1186/1476-8518-1-3","title":"A Canadian national survey of attitudes and knowledge regarding preventive vaccines","year":2003,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Toronto General Hospital; University of Toronto; University Health Network; Ontario Institute for Cancer Research; York University","funders":"","keywords":"Medicine; Telephone survey; Public health; Vaccine safety; Public support; Family medicine; Environmental health; Public relations; Immunization; Nursing; Immunology; Political science; Business","score_opus":0.02702331419940931,"score_gpt":0.31121915042345855,"score_spread":0.28419583622404926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165217477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96906316,0.0011446275,0.00012326511,0.001431991,0.000065835375,0.00026102545,0.017899096,0.00002267775,0.009988346],"genre_scores_gemma":[0.9853334,0.0014257494,0.00046868582,0.0012814624,0.000028359198,0.00015496057,0.0060236375,0.000015494068,0.005268365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745256,0.00021236429,0.00025254767,0.00018774373,0.0012592702,0.00063549547],"domain_scores_gemma":[0.99030733,0.000693278,0.0015187721,0.00022840306,0.004993702,0.0022585655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025669155,0.0006328528,0.0007136335,0.0028064062,0.0040519047,0.0013132134,0.0017543848,0.0013237906,0.0041741254],"category_scores_gemma":[0.0057707923,0.00093583285,0.0013385122,0.0057304804,0.0009152078,0.0008251321,0.0010129253,0.0017788826,0.0010486626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013997359,0.0003004107,0.98553455,0.00010222196,0.00010010504,0.00007604994,0.0022585003,0.00008018262,0.00016465102,0.00011859967,0.0058667893,0.0052578123],"study_design_scores_gemma":[0.000017828597,0.000072923656,0.99623716,0.000047745754,0.000022694236,0.000040424144,0.0013180078,0.00010608742,0.000035935158,0.000014272087,0.0020684523,0.000018364773],"about_ca_topic_score_codex":0.9916909,"about_ca_topic_score_gemma":0.99425864,"teacher_disagreement_score":0.02626163,"about_ca_system_score_codex":0.02626163,"about_ca_system_score_gemma":0.030309435,"threshold_uncertainty_score":0.19054234},"labels":[],"label_agreement":null},{"id":"W2171927847","doi":"10.1186/1476-8518-3-3","title":"Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection","year":2005,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Immunology; Immune system; Immunity; Disease; Intensive care medicine; Antiretroviral therapy; Human immunodeficiency virus (HIV); Viral load; Internal medicine","score_opus":0.01490792995513445,"score_gpt":0.28715157999969426,"score_spread":0.2722436500445598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171927847","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011783535,0.965996,0.0011167305,0.00685884,0.0020377643,0.00009242543,0.000044699686,0.000038535632,0.012031418],"genre_scores_gemma":[0.12493828,0.84805775,0.005123075,0.0076260176,0.0044883406,0.00017374463,0.00015509715,0.000020383197,0.009417256],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997644,0.00010849523,0.00001855207,0.000013277446,0.00008145858,0.000013873343],"domain_scores_gemma":[0.9997818,0.00013170188,0.00002472925,0.000010589038,0.00002483082,0.000026432725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007130608,0.00029004776,0.00038587538,0.00068178936,0.00014262539,0.00041159592,0.00042830806,0.0007738073,0.0013495025],"category_scores_gemma":[0.0006475177,0.000061632265,0.00029792864,0.00047466037,0.0004096032,0.00030926897,0.00032658517,0.0014669097,0.0004055873],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011548509,0.00089329196,0.0009995154,0.001695995,0.00007472676,0.0008539515,0.00010267926,0.0004965276,0.0080042835,0.0073864064,0.015297533,0.96304023],"study_design_scores_gemma":[0.0015712753,0.007825789,0.01164128,0.0026126944,0.0003000903,0.0057180263,0.00009178458,0.0009421105,0.0117710475,0.006480371,0.95100176,0.000043668435],"about_ca_topic_score_codex":0.0005242754,"about_ca_topic_score_gemma":0.0009517859,"teacher_disagreement_score":0.0013495025,"about_ca_system_score_codex":0.00029175615,"about_ca_system_score_gemma":0.00047733102,"threshold_uncertainty_score":0.004514575},"labels":[],"label_agreement":null}]}